Free Trial

Marechale Capital (MAC) Competitors

Marechale Capital logo
GBX 1.60
0.00 (0.00%)
(As of 11/1/2024 ET)

MAC vs. EARN, MRS, EXR, ORM, OSI, NNN, PEL, RENE, PPHP, and EVE

Should you be buying Marechale Capital stock or one of its competitors? The main competitors of Marechale Capital include EARNZ (EARN), Management Resource Solutions (MRS), ENGAGE XR (EXR), Ormonde Mining (ORM), Osirium Technologies (OSI), nanosynth group (NNN), Paragon Entertainment (PEL), ReNeuron Group (RENE), Papillon (PPHP), and eve Sleep (EVE). These companies are all part of the "trading" industry.

Marechale Capital vs.

Marechale Capital (LON:MAC) and EARNZ (LON:EARN) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, community ranking, analyst recommendations, profitability, earnings and media sentiment.

39.7% of EARNZ shares are held by institutional investors. 56.0% of Marechale Capital shares are held by company insiders. Comparatively, 30.0% of EARNZ shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Marechale Capital had 1 more articles in the media than EARNZ. MarketBeat recorded 4 mentions for Marechale Capital and 3 mentions for EARNZ. EARNZ's average media sentiment score of 1.09 beat Marechale Capital's score of 0.16 indicating that EARNZ is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Marechale Capital
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
EARNZ
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Marechale Capital has a beta of 0.42, suggesting that its share price is 58% less volatile than the S&P 500. Comparatively, EARNZ has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.

Marechale Capital has higher revenue and earnings than EARNZ.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marechale Capital£291.31K5.82N/AN/AN/A
EARNZN/AN/A-£2.32M£0.748.72

EARNZ has a net margin of 0.00% compared to Marechale Capital's net margin of -27.38%. Marechale Capital's return on equity of -5.57% beat EARNZ's return on equity.

Company Net Margins Return on Equity Return on Assets
Marechale Capital-27.38% -5.57% -5.40%
EARNZ N/A -128.75%-43.59%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marechale Capital
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
EARNZ
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Marechale Capital received 83 more outperform votes than EARNZ when rated by MarketBeat users.

CompanyUnderperformOutperform
Marechale CapitalOutperform Votes
83
71.55%
Underperform Votes
33
28.45%
EARNZN/AN/A

Summary

Marechale Capital beats EARNZ on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MAC vs. The Competition

MetricMarechale CapitalCapital Markets IndustryFinancial SectorLON Exchange
Market Cap£1.70M£596.63M£3.38B£1.53B
Dividend Yield2.88%4.51%4.51%11.79%
P/E Ratio-170.00309.76412.641,670.48
Price / Sales5.828,536.002,692.94221,312.87
Price / Cash0.5711.1650.4935.27
Price / Book0.532.841.382.95
Net IncomeN/A£55.63M£346.15M£142.89M
7 Day Performance6.67%1.60%-0.54%0.11%
1 Month Performance10.34%9.30%-0.57%-0.15%
1 Year PerformanceN/A55.88%17.17%14.68%

Marechale Capital Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MAC
Marechale Capital
N/AGBX 1.60
flat
N/AN/A£1.70M£291,307.00-170.00650News Coverage
Gap Down
EARN
EARNZ
N/AGBX 6.45
flat
N/AN/A£6.59MN/A8.7211Positive News
MRS
Management Resource Solutions
N/AN/AN/A+0.0%£5.70MN/A1.3412,200
EXR
ENGAGE XR
N/AGBX 0.80
-5.9%
N/AN/A£4.20M£3.82M-80.004,780Gap Down
ORM
Ormonde Mining
N/AGBX 0.75
flat
N/AN/A£3.54MN/A-2.506News Coverage
OSI
Osirium Technologies
N/AGBX 2.20
flat
N/AN/A£2.70M£2.09M-110.003
NNN
nanosynth group
N/AN/AN/AN/A£2.58M£85,650.00-1.1280High Trading Volume
PEL
Paragon Entertainment
N/AN/AN/AN/A£2.37M£10.84M-0.9682,400News Coverage
Positive News
Gap Down
RENE
ReNeuron Group
N/AGBX 3.38
-2.2%
N/A-35.7%£1.93M£783,000.00-37.502Gap Down
PPHP
Papillon
N/AGBX 1.33
flat
N/A+0.0%£1.75MN/A0.003Gap Up
EVE
eve Sleep
N/AGBX 0.53
flat
N/A+0.0%£1.44M£24.29M-0.484Gap Up

Related Companies and Tools


This page (LON:MAC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners